Clinical significance of SETBP1 expression in breast cancer.

被引：0
|
作者：
Ando, Yuki [1 ]
Masuda, Takaaki [1 ]
Hayashi, Naoki [2 ]
Mochizuki, Kenichi [1 ]
Abe, Tadashi [1 ]
Saito, Hideyuki [1 ]
Ozato, Yuki [1 ]
Nakano, Takafumi [1 ]
Koike, Kensuke [1 ]
Motomura, Yushi [1 ]
Takahashi, Junichi [1 ]
Toshima, Takeo [1 ]
Hisamatsu, Yuichi [1 ]
Yonemura, Yusuke [1 ]
Mimori, Koshi [1 ]
机构：
[1] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan
[2] Kagoshima City Hosp, Dept Breast Surg, Kagoshima, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J4-2-4
引用
收藏
页码：741 / 741
页数：1
相关论文
共 50 条
  • [31] SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer
    Ando, Yuki
    Masuda, Takaaki
    Hayashi, Naoki
    Kosai, Keisuke
    Shibuta, Shohei
    Ono, Yuya
    Taro, Tobo
    Otsu, Hajime
    Hisamatsu, Yuichi
    Yoshizumi, Tomoharu
    Mimori, Koshi
    BREAST CANCER, 2025, : 457 - 469
  • [32] The landscape of SETBP1 gene expression and transcription factor activity across human tissues
    Whitlock, Jordan H.
    Wilk, Elizabeth J.
    Howton, Timothy C.
    Clark, Amanda D.
    Lasseigne, Brittany N.
    PLOS ONE, 2024, 19 (01):
  • [33] SETBP1 dysregulation in congenital disorders and myeloid neoplasms
    Coccaro, Nicoletta
    Tota, Giuseppina
    Zagaria, Antonella
    Anelli, Luisa
    Specchia, Giorgina
    Albano, Francesco
    ONCOTARGET, 2017, 8 (31) : 51920 - 51935
  • [34] Prevalence and Clinical Impacts Of SETBP1 Mutation In East Asian Patients With MDS/MPN
    Choi, Hyun-Woo
    Kim, Hye-Ran
    Kim, Hwan-Young
    Park, Ju-Heon
    Ahn, Jae-Sook
    Cho, Duck
    Kee, Seung-Jung
    Kim, Soo-Hyun
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    Shin, Myung-Geun
    BLOOD, 2013, 122 (21)
  • [35] Clinical significance of the tumor expression of PD-L1 in lung cancer.
    De Petris, Luigi
    Ortiz-Villalon, Cristian
    Kis, Lorand
    Tendler, Salomon
    Friesland, Signe
    Lewensohn, Rolf
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Prevalence and clinical follow-up of patients with myeloid disorders and SETBP1 mutations
    Winkelmann, N.
    Schaefer, V
    Waldau, A.
    Rinke, J.
    Mueller, V.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 129 - 129
  • [37] The expression and clinical significance of STAMBP in breast cancer
    Li, Lei
    Yang, Xiaomei
    He, Mengfan
    Xu, Xinchun
    Xuan, Xiaofeng
    Zhang, Jieru
    Zhang, Ling
    Xu, Hui
    Li, Dawei
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (01) : 899 - 906
  • [38] The expression and clinical significance of STAMBP in breast cancer
    Lei Li
    Xiaomei Yang
    Mengfan He
    Xinchun Xu
    Xiaofeng Xuan
    Jieru Zhang
    Ling Zhang
    Hui Xu
    Dawei Li
    Molecular Biology Reports, 2023, 50 : 899 - 906
  • [39] Clinical significance of age in premenopausal women with primary breast cancer.
    Lee, Y. H.
    Jung, J. H.
    Lim, Y. S.
    Park, H. Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S95 - S95
  • [40] Expression and clinical significance of lncRNA-SChLAP1 in breast cancer
    Cheng, Sixian
    Zhao, Qingquan
    Zheng, Zhengrong
    JOURNAL OF BUON, 2021, 26 (03): : 728 - 733
12345